Country Club Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.42M Sell
51,697
-8,402
-14% -$1.03M 0.38% 68
2025
Q2
$7.21M Sell
60,099
-848
-1% -$95.6K 0.45% 57
2025
Q1
$6.86M Sell
60,947
-160
-0.3% -$17K 0.46% 59
2024
Q4
$5.95M Sell
61,107
-25
-0% -$2.67K 0.4% 66
2024
Q3
$7.07M Sell
61,132
-1,427
-2% -$162K 0.47% 61
2024
Q2
$6.67M Sell
62,559
-679
-1% -$68.2K 0.46% 60
2024
Q1
$6.12M Sell
63,238
-1,238
-2% -$127K 0.43% 65
2023
Q4
$6.45M Sell
64,476
-1,212
-2% -$117K 0.49% 61
2023
Q3
$6.72M Sell
65,688
-764
-1% -$77.5K 0.55% 55
2023
Q2
$6.6M Sell
66,452
-3,050
-4% -$305K 0.52% 55
2023
Q1
$6.36M Buy
69,502
+33,585
+94% +$2.93M 0.52% 61
2022
Q4
$3.26M Sell
35,917
-378
-1% -$31.8K 0.28% 91
2022
Q3
$2.78M Sell
36,295
-1,828
-5% -$152K 0.27% 94
2022
Q2
$3.23M Sell
38,123
-6,196
-14% -$544K 0.3% 90
2022
Q1
$3.9M Buy
+44,319
New +$3.84M 0.34% 77

Other funds holding NVS

Country Club Bank's NVS Position: Q3 2025 in Review

Country Club Bank reduced its Novartis (NVS) stake by 14% in Q3 2025, selling an estimated $1.03M and leaving 51,697 shares worth $6.42M. The position accounts for 0.38% of the portfolio, ranked #68.

Country Club Bank first reported a position in NVS in Q1 2022 and has held it in 15 quarters since. The position peaked at $7.21M in Q2 2025. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Country Club Bank held 51,697 shares of Novartis worth $6.42M as of Q3 2025.
  • Country Club Bank sold 8,402 Novartis shares in Q3 2025, an estimated $1.03M.
  • Novartis made up 0.38% of Country Club Bank's portfolio in Q3 2025, its #68 holding.
  • Country Club Bank first reported a position in Novartis in Q1 2022 and has held it in 15 quarters since.
  • Country Club Bank's Novartis position peaked at $7.21M in Q2 2025.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Country Club Bank's 13F filing for Q3 2025, filed 8 Oct 2025.